Aptose Biosciences Inc.
(Toronto Stock Exchange : APTO)

( )
APTO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.81%174.661.2%$575.79m
CELGCelgene Corporation
0.60%89.491.2%$535.84m
GILDGilead Sciences, Inc.
0.42%74.010.9%$421.63m
BIIBBiogen Inc.
-1.41%259.301.2%$416.64m
REGNRegeneron Pharmaceuticals, Inc.
0.56%316.012.7%$245.42m
INCYIncyte Corporation
-0.42%68.142.5%$245.05m
VRTXVertex Pharmaceuticals Incorporated
0.34%158.691.9%$226.49m
ALXNAlexion Pharmaceuticals, Inc.
0.05%107.832.0%$209.17m
NKTRNektar Therapeutics
-0.88%85.456.0%$201.71m
ILMNIllumina, Inc.
0.51%245.853.5%$184.02m
AAgilent Technologies, Inc.
0.74%68.051.5%$157.16m
ALNYAlnylam Pharmaceuticals, Inc
-1.66%95.869.8%$140.19m
BLUEBluebird Bio, Inc.
-1.32%168.2515.8%$127.75m
EXASExact Sciences Corporation
2.48%48.7025.7%$111.34m
BMRNBioMarin Pharmaceutical Inc.
-0.27%82.084.4%$104.77m

Company Profile

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product portfolio includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG'806. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.